Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Generics may not have the same cost-lowering power for specialty medicines, such as multiple sclerosis drugs, researchers find. That

Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here’s why.

(Image credit: Gary Waters/Ikon Images/Getty Images)

Read the full post on Health Care : NPR

Sydney Lupkin